4.4 Article

Influenza A virus preferentially snatches noncoding RNA caps

期刊

RNA
卷 21, 期 12, 页码 2067-2075

出版社

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1261/rna.054221.115

关键词

cap-snatching; influenza; noncoding RNA

资金

  1. NIAID NIH HHS [T32 AI007349, T32 AI095213] Funding Source: Medline

向作者/读者索取更多资源

Influenza A virus (IAV) lacks the enzyme for adding 5' caps to its RNAs and snatches the 5' ends of host capped RNAs to prime transcription. Neither the preference of the host RNA sequences snatched nor the effect of cap-snatching on host processes is completely defined. Previous studies of influenza cap-snatching used poly(A)-selected RNAs from infected cells or relied on annotated host genes to define the snatched host RNAs, and thus lack details on many noncoding host RNAs including snRNAs, snoRNAs, and promoter-associated capped small (cs)RNAs, which are made by paused Pol II during transcription initiation. In this study, we used a nonbiased technique, CapSeq, to identify host and viral-capped RNAs including nonpolyadenylated RNAs in the same samples, and investigated the substrate product correlation between the host RNAs and the viral RNAs. We demonstrated that noncoding host RNAs, particularly U1 and U2, are the preferred cap-snatching source over mRNAs or pre-mRNAs. We also found that csRNAs are highly snatched by IAV. Because the functions of csRNAs remain mostly unknown, especially in somatic cells, our finding reveals that csRNAs at least play roles in the process of IAV infection. Our findings support a model where nascent RNAs including csRNAs are the preferred targets for cap-snatching by IAV and raise questions about how IAV might use snatching preferences to modulate host-mRNA splicing and transcription.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemical Research Methods

Boosting predictabilities of agronomic traits in rice using bivariate genomic selection

Shibo Wang, Yang Xu, Han Qu, Yanru Cui, Ruidong Li, John M. Chater, Lei Yu, Rui Zhou, Renyuan Ma, Yuhan Huang, Yiru Qiao, Xuehai Hu, Weibo Xie, Zhenyu Jia

Summary: In this study, a highly efficient bivariate genomic selection method was developed and demonstrated significant advantages over univariate methods in predicting traditional traits in rice. The incorporation of the HAT methodology in the 2D BLUP GS model increased computational efficiency by avoiding conventional cross-validation. Selected metabolites can further enhance predictability of traditional traits in the new 2D BLUP-HAT GS method.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Genetics & Heredity

Identification of Four Potential Biomarkers Associated With Coronary Artery Disease in Non-diabetic Patients by Gene Co-expression Network Analysis

Min Jiao, Jingtian Li, Quan Zhang, Xiufeng Xu, Ruidong Li, Peikang Dong, Chun Meng, Yi Li, Lijuan Wang, Wanpeng Qi, Kai Kang, Hongjie Wang, Tao Wang

FRONTIERS IN GENETICS (2020)

Article Biochemical Research Methods

Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer

Ruidong Li, Shibo Wang, Yanru Cui, Han Qu, John M. Chater, Le Zhang, Julong Wei, Meiyue Wang, Yang Xu, Lei Yu, Jianming Lu, Yuanfa Feng, Rui Zhou, Yuhan Huang, Renyuan Ma, Jianguo Zhu, Weide Zhong, Zhenyu Jia

Summary: This study utilized genomic selection and omics data, particularly the BLUP model and BLUP-HAT method, to predict the prognosis of prostate cancer. The results indicated that these methods performed well in increasing the reliability of outcome prediction.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Biochemical Research Methods

Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson's disease

Xiaoya Gao, Zifeng Huang, Cailing Feng, Chaohao Guan, Ruidong Li, Haiting Xie, Jian Chen, Mingchun Li, Rongfang Que, Bin Deng, Peihua Cao, Mengyan Li, Jianjun Lu, Yihong Huang, Minzi Li, Weihong Yang, Xiaohua Yang, Chunyan Wen, Xiaomei Liang, Qin Yang, Yin-Xia Chao, Ling-Ling Chan, Midori A. Yenari, Kunlin Jin, K. Ray Chaudhuri, Jing Zhang, Eng-King Tan, Qing Wang

Summary: This study aimed to identify key susceptibility gene targets in postmortem brains and blood of Parkinson's disease (PD) patients and healthy controls (HC). Multitiered analysis integrated gene expression data from 244 human postmortem tissues, resulting in the identification of hub node genes related to PD in a consensus module. Validation in 238 subjects revealed promising markers, especially SYNJ1, for discriminating PD from HCs and Parkinson's Plus Syndrome (PPS), highlighting the potential of SYNJ1 in PD diagnosis and treatment.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Medicine, General & Internal

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

A. C. Kalil, T. F. Patterson, A. K. Mehta, K. M. Tomashek, C. R. Wolfe, V. Ghazaryan, V. C. Marconi, G. M. Ruiz-Palacios, L. Hsieh, S. Kline, V. Tapson, N. M. Iovine, M. K. Jain, D. A. Sweeney, H. M. El Sahly, A. R. Branche, J. Regalado Pineda, D. C. Lye, U. Sandkovsky, A. F. Luetkemeyer, S. H. Cohen, R. W. Finberg, P. E. H. Jackson, B. Taiwo, C. I. Paules, H. Arguinchona, N. Erdmann, N. Ahuja, M. Frank, M. Oh, E. -S. Kim, S. Y. Tan, R. A. Mularski, H. Nielsen, P. O. Ponce, B. S. Taylor, L. A. Larson, N. G. Rouphael, Y. Saklawi, V. D. Cantos, E. R. Ko, J. J. Engemann, A. N. Amin, M. Watanabe, J. Billings, M. -C. Elie, R. T. Davey, T. H. Burgess, J. Ferreira, M. Green, M. Makowski, A. Cardoso, S. de Bono, T. Bonnett, M. Proschan, G. A. Deye, W. Dempsey, S. U. Nayak, L. E. Dodd, J. H. Beigel

Summary: Combination treatment with baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events

Jacob E. Lemieux, Katherine J. Siddle, Bennett M. Shaw, Christine Loreth, Stephen F. Schaffner, Adrianne Gladden-Young, Gordon Adams, Timelia Fink, Christopher H. Tomkins-Tinch, Lydia A. Krasilnikova, Katherine C. DeRuff, Melissa Rudy, Matthew R. Bauer, Kim A. Lagerborg, Erica Normandin, Sinead B. Chapman, Steven K. Reilly, Melis N. Anahtar, Aaron E. Lin, Amber Carter, Cameron Myhrvold, Molly E. Kemball, Sushma Chaluvadi, Caroline Cusick, Katelyn Flowers, Anna Neumann, Felecia Cerrato, Maha Farhat, Damien Slater, Jason B. Harris, John A. Branda, David Hooper, Jessie M. Gaeta, Travis P. Baggett, James O'Connell, Andreas Gnirke, Tami D. Lieberman, Anthony Philippakis, Meagan Burns, Catherine M. Brown, Jeremy Luban, Edward T. Ryan, Sarah E. Turbett, Regina C. LaRocque, William P. Hanage, Glen R. Gallagher, Lawrence C. Madoff, Sandra Smole, Virginia M. Pierce, Eric Rosenberg, Pardis C. Sabeti, Daniel J. Park, Bronwyn L. MacInnis

Summary: Analysis of 772 complete genomes of SARS-CoV-2 from early in the Boston-area epidemic shows multiple introductions of the virus, with two distinct superspreading events. One at a nursing facility resulted in rapid transmission and significant mortality, while the other at an international business conference led to sustained community transmission and widespread spread. The genetic variation generated by these events differed substantially, indicating varying transmission dynamics in superspreading events.

SCIENCE (2021)

Article Multidisciplinary Sciences

Unique structural solution from a VH3-30 antibody targeting the hemagglutinin stem of influenza A viruses

Wayne D. Harshbarger, Derrick Deming, Gordon J. Lockbaum, Nattapol Attatippaholkun, Maliwan Kamkaew, Shurong Hou, Mohan Somasundaran, Jennifer P. Wang, Robert W. Finberg, Quan Karen Zhu, Celia A. Schiffer, Wayne A. Marasco

Summary: This study presents structural details of the human antibody 3I14 recognizing HA from various influenza A viruses, highlighting the binding mechanism and potential implications for universal vaccine design.

NATURE COMMUNICATIONS (2021)

Article Microbiology

The chromatin-remodeling protein BAF60/SWP73A regulates the plant immune receptor NLRs

Chien-Yu Huang, Diana Sanchez Rangel, Xiaobo Qin, Christine Bui, Ruidong Li, Zhenyu Jia, Xinping Cui, Hailing Jin

Summary: Both plant and animal innate immune responses are mediated by membrane-associated receptors and NLRs. The regulation of NLRs is crucial to prevent autoimmune responses, and the chromatin-remodeling protein SWP73A plays a role in suppressing NLR expression and splicing. Bacteria-induced small RNAs can silence SWP73A to activate NLRs during infection.

CELL HOST & MICROBE (2021)

Article Cardiac & Cardiovascular Systems

SARS-CoV-2 Initiates Programmed Cell Death in Platelets

Milka Koupenova, Heather A. Corkrey, Olga Vitseva, Kahraman Tanriverdi, Mohan Somasundaran, Ping Liu, Shaukat Soofi, Rohan Bhandari, Matthew Godwin, Krishna Mohan Parsi, Alyssa Cousineau, Rene Maehr, Jennifer P. Wang, Scott J. Cameron, Jeffrey Rade, Robert W. Finberg, Jane E. Freedman

Summary: The study revealed that platelets in COVID-19 patients contain viral RNA and proteins, and that SARS-CoV-2 can directly influence platelet internalization and cell death, which may contribute to complications like thrombosis.

CIRCULATION RESEARCH (2021)

Article Multidisciplinary Sciences

High-throughput human primary cell-based airway model for evaluating influenza, coronavirus, or other respiratory viruses in vitro

A. L. Gard, R. J. Luu, C. R. Miller, R. Maloney, B. P. Cain, E. E. Marr, D. M. Burns, R. Gaibler, T. J. Mulhern, C. A. Wong, J. Alladina, J. R. Coppeta, P. Liu, J. P. Wang, H. Azizgolshani, R. Fennell Fezzie, J. L. Balestrini, B. C. Isenberg, B. D. Medoff, R. W. Finberg, J. T. Borenstein

Summary: This study integrates human primary airway epithelial cells into a custom-engineered 96-device platform, and applies it to evaluate viral infection kinetics and antiviral agent dosing for influenza A virus and coronavirus infections across various human primary cell populations. This new capability can help address the rapid assessment of therapeutic efficacy against respiratory viruses, including coronaviruses.

SCIENTIFIC REPORTS (2021)

Article Virology

Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y

Li Jiang, Neha Samant, Ping Liu, Mohan Somasundaran, Jeffrey D. Jensen, Wayne A. Marasco, Timothy F. Kowalik, Celia A. Schiffer, Robert W. Finberg, Jennifer P. Wang, Daniel N. A. Bolon

Summary: Understanding the evolutionary mechanisms that impact drug resistance in influenza A virus (IAV) is crucial for developing surveillance and treatment strategies due to its potential to cause pandemics. A new helper mutation, Y276F, has been identified to rescue the functional defects of the main oseltamivir resistance mutation, H275Y, and contribute to the evolution of drug resistance in IAV.

JOURNAL OF VIROLOGY (2022)

Article Medicine, Research & Experimental

Human nasal wash RNA-Seq reveals distinct cell-specific innate immune responses in influenza versus SARS-CoV-2

Kevin M. Gao, Alan G. Derr, Zhiru Guo, Kerstin Nundel, Ann Marshak-Rothstein, Robert W. Finberg, Jennifer P. Wang

Summary: The study found that macrophages and neutrophils are increased in nasal wash cells of patients infected with COVID-19 and influenza, with an enrichment of specific cell types such as hillock-like epithelial cells, M2-like macrophages, and age-dependent B cells in COVID-19 samples. Compared to influenza, a global decrease in IFN-associated transcripts in neutrophils, macrophages, and epithelial cells was observed in COVID-19 samples.

JCI INSIGHT (2021)

Article Critical Care Medicine

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M. Tomashek, Thomas F. Patterson, Carlos A. Gomez, Vincent C. Marconi, Mamta K. Jain, Otto O. Yang, Catharine Paules, Guillermo M. Ruiz Palacios, Robert Grossberg, Michelle S. Harkins, Richard A. Mularski, Nathaniel Erdmann, Uriel Sandkovsky, Eyad Almasri, Justino Regalado Pineda, Alexandra W. Dretler, Diego Lopez de Castilla, Angela R. Branche, Pauline K. Park, Aneesh K. Mehta, William R. Short, Susan L. F. McLellan, Susan Kline, Nicole M. Iovine, Hana M. El Sahly, Sarah B. Doernberg, Myoung-don Oh, Nikhil Huprikar, Elizabeth Hohmann, Colleen F. Kelley, Mark Holodniy, Eu Suk Kim, Daniel A. Sweeney, Robert W. Finberg, Kevin A. Grimes, Ryan C. Maves, Emily R. Ko, John J. Engemann, Barbara S. Taylor, Philip O. Ponce, LuAnn Larson, Dante Paolo Melendez, Allan M. Seibert, Nadine G. Rouphael, Joslyn Strebe, Jesse L. Clark, Kathleen G. Julian, Alfredo Ponce de Leon, Anabela Cardoso, Stephanie de Bono, Robert L. Atmar, Anuradha Ganesan, Jennifer L. Ferreira, Michelle Green, Mat Makowski, Tyler Bonnett, Tatiana Beresnev, Varduhi Ghazaryan, Walla Dempsey, Seema U. Nayak, Lori E. Dodd, John H. Beigel, Andre C. Kalil

Summary: In hospitalized patients with COVID-19 requiring supplemental oxygen by low-flow, high-flow, or non-invasive ventilation, baricitinib plus remdesivir and dexamethasone plus remdesivir resulted in similar mechanical ventilation-free survival by day 29, but dexamethasone was associated with significantly more adverse events, treatment-related adverse events, and severe or life-threatening adverse events.

LANCET RESPIRATORY MEDICINE (2022)

Article Virology

A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants

Ching-Wen Chang, Krishna Mohan Parsi, Mohan Somasundaran, Emma Vanderleeden, Ping Liu, John Cruz, Alyssa Cousineau, Robert W. Finberg, Evelyn A. Kurt-Jones

Summary: Researchers have successfully generated a human cell line for studying SARS-CoV-2 by transducing human ACE2 and TMPRSS2 into A549 cells. These cells are susceptible to infection by SARS-CoV-2, including the delta and omicron variants. Additionally, several antiviral drugs showed strong inhibitory effects against SARS-CoV-2 variants in this cell model.

VIRUSES-BASEL (2022)

暂无数据